Trial Profile
A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Jun 2023
Price :
$35
*
At a glance
- Drugs Iodine-124-monoclonal antibody A33 (Primary) ; Iodine-124-monoclonal antibody A33 (Primary) ; Immune globulin
- Indications Carcinoma; Colorectal cancer
- Focus Adverse reactions; Diagnostic use
- 26 May 2023 Planned End Date changed from 1 Jun 2024 to 1 Jun 2027.
- 26 May 2023 Planned primary completion date changed from 1 Jun 2024 to 1 Jun 2027.
- 30 Mar 2023 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.